Suggested Categories:

  • Pathogenesis, molecular biology and virology
  • Epidemiology and natural history 
  • Screening and diagnostics
  • Treatment
  • Multi-zonal/multi-site disease
  • Vaccination
  • Sexual health 
  • Access to care
  • Other anal neoplasia related topics

IANS is now accepting abstract submissions for IANS Rapid Research Update Meeting 2021

Due to the COVID-19 pandemic, the IANS 2021Scientific Meeting was postponed, and will be rescheduled to a later date. The purpose of this Rapid Research Update session is to provide a forum for clinicians and researchers working in the area of anal dysplasia and anal cancer to present their research (can either be completed or a work-in-progress). We strongly encourage submissions from trainees and students.  Please email submissions to

Submit your research by 11.59pm U.S. EDT on April 19, 2021. Abstract authors will be notified of the status of their submission after their abstracts have been reviewed. Be sure to read and adhere to the Abstract Terms and Conditions listed below.

Terms and Conditions

  • Abstracts are not eligible for consideration if the data have previously been presented or published at a U.S. or international meeting held before the IANS Rapid Research Update Meeting.

  • Each presenting author will be asked to comply with the IANS Disclosure Policy. Indication of the relationship, the associated commercial entity and level of support is required for each presenting author. All presenters at IANS Rapid Research Update Meeting must display a slide at the beginning of their presentation indicating disclosure information as applicable, or that they have nothing to disclose.

  • The submitter acts on behalf of all co-authors and in submitting an abstract, transfers to IANS the copyright and all other rights in the material comprising the application if the application is accepted. Co-authors reserve the following:
      • All proprietary rights other than copyright, such as patent rights; and
      • The right to use all or part of the application in future works of their own. The meeting organizers, as holder of the copyright on the accepted application, reserve all rights of reproduction, distribution, performance, display, and the right to create derivative works in both print and digital formats.
  • Abstract submissions will be reviewed by IANS Scientific Meeting Committee.

The International Anal Neoplasia Society

P.O. Box 1543
Leesburg, Virginia 20177

Powered by Wild Apricot Membership Software